14-18601262-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001013354.1(OR11H12):c.146C>T(p.Thr49Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000307 in 1,604,654 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001013354.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR11H12 | NM_001013354.1 | c.146C>T | p.Thr49Ile | missense_variant | 1/1 | ENST00000550708.2 | NP_001013372.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR11H12 | ENST00000550708.2 | c.146C>T | p.Thr49Ile | missense_variant | 1/1 | 6 | NM_001013354.1 | ENSP00000449002.1 |
Frequencies
GnomAD3 genomes AF: 0.00159 AC: 232AN: 145688Hom.: 7 Cov.: 20
GnomAD3 exomes AF: 0.0000923 AC: 23AN: 249220Hom.: 3 AF XY: 0.0000518 AC XY: 7AN XY: 135082
GnomAD4 exome AF: 0.000179 AC: 261AN: 1458850Hom.: 6 Cov.: 31 AF XY: 0.000156 AC XY: 113AN XY: 725812
GnomAD4 genome AF: 0.00159 AC: 232AN: 145804Hom.: 7 Cov.: 20 AF XY: 0.00158 AC XY: 112AN XY: 71088
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.146C>T (p.T49I) alteration is located in exon 1 (coding exon 1) of the OR11H12 gene. This alteration results from a C to T substitution at nucleotide position 146, causing the threonine (T) at amino acid position 49 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at